FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Reserpine Tablets
Status: Currently in Shortage
»Date first posted: 04/17/2013
»Therapeutic Categories: Cardiovascular; Pediatric

Expand all

Sandoz (Reverified 06/17/2016)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg 100s (NDC 0185-0134-01) currently unavailable, estimated recovery TBD. API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
0.25 mg 1000s (NDC 0185-0134-10) currently unavailable, estimated recovery TBD. API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
0.1 mg 100s (NDC 0185-0032-01) currently unavailable, estimated recovery TBD. API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process
0.1 mg 1000s (NDC 0185-0032-10) currently unavailable, estimated recovery TBD. API and Raw Material changes required, changes currently in process API and Raw Material changes. required, changes currently in process

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.